» Articles » PMID: 33928376

Heterologous Production of Cyanobacterial Compounds

Overview
Specialty Biotechnology
Date 2021 Apr 30
PMID 33928376
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cyanobacteria produce a plethora of compounds with unique chemical structures and diverse biological activities. Importantly, the increasing availability of cyanobacterial genome sequences and the rapid development of bioinformatics tools have unraveled the tremendous potential of cyanobacteria in producing new natural products. However, the discovery of these compounds based on cyanobacterial genomes has progressed slowly as the majority of their corresponding biosynthetic gene clusters (BGCs) are silent. In addition, cyanobacterial strains are often slow-growing, difficult for genetic engineering, or cannot be cultivated yet, limiting the use of host genetic engineering approaches for discovery. On the other hand, genetically tractable hosts such as Escherichia coli, Actinobacteria, and yeast have been developed for the heterologous expression of cyanobacterial BGCs. More recently, there have been increased interests in developing model cyanobacterial strains as heterologous production platforms. Herein, we present recent advances in the heterologous production of cyanobacterial compounds in both cyanobacterial and noncyanobacterial hosts. Emerging strategies for BGC assembly, host engineering, and optimization of BGC expression are included for fostering the broader applications of synthetic biology tools in the discovery of new cyanobacterial natural products.

Citing Articles

Exploring the uncharted seas: Metabolite profiling unleashes the anticancer properties of .

Das B, Prusty A, Dutta S, Maulik A, Dahat Y, Kumar D Heliyon. 2024; 10(16):e36048.

PMID: 39224332 PMC: 11367535. DOI: 10.1016/j.heliyon.2024.e36048.


Heterologous Production of the C33-C45 Polyketide Fragment of Anticancer Apratoxins in a Cyanobacterial Host.

Dhakal D, Kallifidas D, Chen M, Kokkaliari S, Chen Q, Paul V Org Lett. 2023; 25(13):2238-2242.

PMID: 36961224 PMC: 10198461. DOI: 10.1021/acs.orglett.3c00462.


Incorporation and modification of fatty acids in cyanobacterial natural products biosynthesis.

Leao P, Martins T, Abt K, Reis J, Figueiredo S, Castelo-Branco R Chem Commun (Camb). 2023; 59(30):4436-4446.

PMID: 36960756 PMC: 10088813. DOI: 10.1039/d3cc00136a.


Biosynthesis of Lyngbyastatins 1 and 3, Cytotoxic Depsipeptides from an sp. Marine Cyanobacterium.

Dhakal D, Kokkaliari S, Rubin G, Paul V, Ding Y, Luesch H J Nat Prod. 2022; 86(1):85-93.

PMID: 36546857 PMC: 10197921. DOI: 10.1021/acs.jnatprod.2c00782.


Discovery and Heterologous Expression of Microginins from LEGE 91341.

Eusebio N, Castelo-Branco R, Sousa D, Preto M, DAgostino P, Gulder T ACS Synth Biol. 2022; 11(10):3493-3503.

PMID: 36166626 PMC: 9594780. DOI: 10.1021/acssynbio.2c00389.


References
1.
Wendt K, Ungerer J, Cobb R, Zhao H, Pakrasi H . CRISPR/Cas9 mediated targeted mutagenesis of the fast growing cyanobacterium Synechococcus elongatus UTEX 2973. Microb Cell Fact. 2016; 15(1):115. PMC: 4917971. DOI: 10.1186/s12934-016-0514-7. View

2.
Bond C, Tang Y . Engineering Saccharomyces cerevisiae for production of simvastatin. Metab Eng. 2018; 51:1-8. PMC: 6348118. DOI: 10.1016/j.ymben.2018.09.005. View

3.
Wang M, Jarmusch A, Vargas F, Aksenov A, Gauglitz J, Weldon K . Mass spectrometry searches using MASST. Nat Biotechnol. 2020; 38(1):23-26. PMC: 7236533. DOI: 10.1038/s41587-019-0375-9. View

4.
Salvador-Reyes L, Luesch H . Biological targets and mechanisms of action of natural products from marine cyanobacteria. Nat Prod Rep. 2015; 32(3):478-503. PMC: 4344435. DOI: 10.1039/c4np00104d. View

5.
Tan L, Phyo M . Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets. Molecules. 2020; 25(9). PMC: 7249205. DOI: 10.3390/molecules25092197. View